Ephrin-A1 and the sheddase ADAM12 are upregulated in COVID-19
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Memorial Sloan Kettering Cancer Center
This publication has 37 references indexed in Scilit:
- Ephs and ephrins resurface in inflammation, immunity, and atherosclerosisPharmacological Research, 2013
- Eph/Ephrin Signaling in Injury and InflammationThe American Journal of Pathology, 2012
- EphA2 Activation Promotes the Endothelial Cell Inflammatory ResponseArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- Active Metalloproteases of the A Disintegrin And Metalloprotease (ADAM) Family: Biological Function and StructureJournal of Proteome Research, 2010
- EphA2 receptor mediates increased vascular permeability in lung injury due to viral infection and hypoxiaAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2009
- Receptor tyrosine kinase EphA2 mediates thrombin-induced upregulation of ICAM-1 in endothelial cells in vitroThrombosis Research, 2009
- Endothelial EphA receptor stimulation increases lung vascular permeabilityAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Cell–cell signaling via Eph receptors and ephrinsCurrent Opinion in Cell Biology, 2007
- ADAMs in cancer cell proliferation and progressionCancer Science, 2007
- Putative dual role of ephrin-Eph receptor interactions in inflammationIUBMB Life, 2006